Efficacy of atropine for myopia control in children: A meta-analysis of randomized controlled trials

Objective: To conduct a meta-analysis of randomized controlled trials (RCTs) on the effects of atropine eye drop in slowing myopia progression. Methods: A systematic search of relevant articles was done through a computerized search on PubMed, Medline, Cochrane Library, and Google Scholar on June 16...

Full description

Bibliographic Details
Main Authors: Shalini Kumari, Raj Anand, Shashank Tripathi, Rajesh C Mishra, Simant Kumar Jha
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Journal of Family Medicine and Primary Care
Subjects:
Online Access:http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=11;spage=6668;epage=6677;aulast=Kumari
_version_ 1797954876403089408
author Shalini Kumari
Raj Anand
Shashank Tripathi
Rajesh C Mishra
Simant Kumar Jha
author_facet Shalini Kumari
Raj Anand
Shashank Tripathi
Rajesh C Mishra
Simant Kumar Jha
author_sort Shalini Kumari
collection DOAJ
description Objective: To conduct a meta-analysis of randomized controlled trials (RCTs) on the effects of atropine eye drop in slowing myopia progression. Methods: A systematic search of relevant articles was done through a computerized search on PubMed, Medline, Cochrane Library, and Google Scholar on June 16, 2022. A supplementary search was done on ClinicalTrials.gov on the same date. After thorough search and analysis, seven relevant RCTs, double-masked with atropine eye drop as intervention arm and placebo as control arm, were selected for meta-analysis. Jadad scoring was used to evaluate the quality of RCTs. The outcome measurements included in the present meta-analysis are mean changes in the spherical equivalent (SE) of myopic error, and mean changes in axial length (AL) during the study period. Result: Pooled summary effect size, calculated by random effect model, for SE of myopia progression was 1.08 with 95% confidence interval (CI) (0.31–1.86) which was statistically significant (P-value = 0.006). Pooled summary effect size, calculated by random effect model, for axial length was − 0.89 with 95% CI (−1.48 to − 0.30) which was statistically significant (P-value = 0.003). Conclusion: In summary, atropine was demonstrated to be effective in controlling myopia progression in children. Both outcome measures, mean SE changes and mean AL elongation responded to atropine intervention compared to placebo.
first_indexed 2024-04-10T23:25:28Z
format Article
id doaj.art-9a93faa052064824aedadf903e4e56c1
institution Directory Open Access Journal
issn 2249-4863
language English
last_indexed 2024-04-10T23:25:28Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Family Medicine and Primary Care
spelling doaj.art-9a93faa052064824aedadf903e4e56c12023-01-12T12:42:32ZengWolters Kluwer Medknow PublicationsJournal of Family Medicine and Primary Care2249-48632022-01-0111116668667710.4103/jfmpc.jfmpc_1339_22Efficacy of atropine for myopia control in children: A meta-analysis of randomized controlled trialsShalini KumariRaj AnandShashank TripathiRajesh C MishraSimant Kumar JhaObjective: To conduct a meta-analysis of randomized controlled trials (RCTs) on the effects of atropine eye drop in slowing myopia progression. Methods: A systematic search of relevant articles was done through a computerized search on PubMed, Medline, Cochrane Library, and Google Scholar on June 16, 2022. A supplementary search was done on ClinicalTrials.gov on the same date. After thorough search and analysis, seven relevant RCTs, double-masked with atropine eye drop as intervention arm and placebo as control arm, were selected for meta-analysis. Jadad scoring was used to evaluate the quality of RCTs. The outcome measurements included in the present meta-analysis are mean changes in the spherical equivalent (SE) of myopic error, and mean changes in axial length (AL) during the study period. Result: Pooled summary effect size, calculated by random effect model, for SE of myopia progression was 1.08 with 95% confidence interval (CI) (0.31–1.86) which was statistically significant (P-value = 0.006). Pooled summary effect size, calculated by random effect model, for axial length was − 0.89 with 95% CI (−1.48 to − 0.30) which was statistically significant (P-value = 0.003). Conclusion: In summary, atropine was demonstrated to be effective in controlling myopia progression in children. Both outcome measures, mean SE changes and mean AL elongation responded to atropine intervention compared to placebo.http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=11;spage=6668;epage=6677;aulast=Kumariatropinechildrenmyopiaprogressionrefractive errorvision
spellingShingle Shalini Kumari
Raj Anand
Shashank Tripathi
Rajesh C Mishra
Simant Kumar Jha
Efficacy of atropine for myopia control in children: A meta-analysis of randomized controlled trials
Journal of Family Medicine and Primary Care
atropine
children
myopia
progression
refractive error
vision
title Efficacy of atropine for myopia control in children: A meta-analysis of randomized controlled trials
title_full Efficacy of atropine for myopia control in children: A meta-analysis of randomized controlled trials
title_fullStr Efficacy of atropine for myopia control in children: A meta-analysis of randomized controlled trials
title_full_unstemmed Efficacy of atropine for myopia control in children: A meta-analysis of randomized controlled trials
title_short Efficacy of atropine for myopia control in children: A meta-analysis of randomized controlled trials
title_sort efficacy of atropine for myopia control in children a meta analysis of randomized controlled trials
topic atropine
children
myopia
progression
refractive error
vision
url http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=11;spage=6668;epage=6677;aulast=Kumari
work_keys_str_mv AT shalinikumari efficacyofatropineformyopiacontrolinchildrenametaanalysisofrandomizedcontrolledtrials
AT rajanand efficacyofatropineformyopiacontrolinchildrenametaanalysisofrandomizedcontrolledtrials
AT shashanktripathi efficacyofatropineformyopiacontrolinchildrenametaanalysisofrandomizedcontrolledtrials
AT rajeshcmishra efficacyofatropineformyopiacontrolinchildrenametaanalysisofrandomizedcontrolledtrials
AT simantkumarjha efficacyofatropineformyopiacontrolinchildrenametaanalysisofrandomizedcontrolledtrials